Related Experiment Video
Updated: Aug 16, 2026

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Influenza vaccination in the elderly: can efficacy be enhanced?
1William S. Middleton VA Hospital, Madison, Wisconsin.
Abstract:
Influenza remains a major cause of illness and death in geriatric populations, especially in the frail elderly and those who live in nursing homes. Influenza vaccine has been useful in reducing morbidity and mortality; however, the vaccine is not uniformly successful in preventing infection, particularly in those people who are immunocompromised. In this article, the rationale and expectations for the current vaccine are reviewed and strategies to enhance vaccine efficacy are presented.
Related Concept Videos
Vaccinations
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacodynamics in Geriatric Patients: Effects of Age
Influenza

